Abstract:Background The sirolimus and paclitaxel distribution patterns and tissue residence time may be modified in atherosclerotic lesions for patients with diabetes, and the biological mechanisms of action for these agents differ significantly. Previous clinical trials have yielded discrepant results of major adverse cardiac events and restenosis between a sirolimus-eluting stent and a paclitaxel-eluting stent in coronary artery disease. Therefore, this study was conduced to compare in-hospital and long-term clinical outcomes between patients receiving sirolimus-eluting stent (Cypher or Cypher Select stent) and paclitaxel-eluting stent (Taxus Express stent) after percutaneous intervention (PCI) in Chinese patients with diabetes. Methods One hundred and sixty-four consecutive diabetic patients underwent PCI in Fuwai Hospital from April 2004 to December 2004. Of them, 101 patients received Cypher or Cypher Select stents (Cypher group, 145 stents) and 63 patients received Taxus Express stents (Taxus group, 129 stents). Repeat coronary angiography was performed at 6-month and clinical outcomes were evaluated at 1- and 3-year follow-up. Stent thrombosis was classified according to Academic Research Consortium (ARC). Results The two groups did not differ significantly with respect to cardiac death, recurrent myocardial infarction (re-MI), target vessel revascularization (TVR) and occurrence of major adverse cardiac events (MACE). And the MACE-free cumulative survival at 1- and 3-year follow-up and early, late and very late thrombosis rates were also similar in the two groups (all P>0.05). There was a trend favoring PES over SES with regard to reducing cardiac death (0 vs 2.0%, P=0.524), re-MI (0 vs 2.0%, P=0.524), the composite of the cardiac death and re-MI (0 vs 4.0%, P=0.299) and very late thrombosis (0 vs 3.0%, P=0.295) between 1-year and 3-year follow-up. Conclusion The study indicates that PCI with either Cypher or Taxus stents is associated with similar efficacy and safety in the small population of Chinese diabetic patients during long-term follow-up.

One Year Comparison of Cypher~(TM) Stent and Taxus~(TM) Stent Implantation by Intravascular Ultrasound

Comparison of the “late Catch-Up” Phenomenon Between BuMA Supreme and XIENCE Stents Through Serial Optical Coherence Tomography at 1–2 Month and 2 Year Follow-Ups: A Multicenter Study

A randomized comparison of healing response of the BuMA Supreme stent and Xience stent at one- and two-month follow-up: PIONEER-II OCT randomized controlled trial.

Comparison of In-Hospital and Long-Term Outcomes Between a Cypher Stent and a Taxus Stent in Chinese Diabetic Patients with Coronary Artery Disease

Comparison of Short- and Mid-Term Outcomes Between CYPHER and TAXUS Stents in Patients with Complex Lesions of the Coronary Arteries

Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.

A study of treatment with different drug eluting stents in coronary heart disease

One-year Clinical Outcomes of Domestic Sirolimus-Eluting Stent in Treating Unselected Patients with Coronary Artery Disease

An Intravascular Ultrasound Study of Cypher, Taxus, and Endeavor Stents on Relation Between Neointimal Proliferation and Residual Plaque Burden

[Comparison of Rapamycin and Paclitaxel Eluting Stent in Patients with Multi-Vessel Coronary Disease].

Evaluation of the coronary in-stent restenosis and neointimal hyperplasia between two kinds of drug eluting stent implantation under intravenous ultrasound

Effectiveness of drug eluting stents in patients with small coronary artery lesions

Comparison of paclitaxal vs. sirolimus eluting stents with bio-degradable polymer for the treatment of coronary bifurcation lesions: subgroup analysis from DKCRUSH-I and DKCRUSH-II studies.

[The Safety and Efficacy of Cypher Drug-Eluting Stent: Results from a Six Months Follow-Up Study in Patients with ST-segment Elevation Myocardial Infarction].

The Clinical Study of CYPHER ~(TM) Stent in Long Lesion of Left Anterior Descending Artery

Clinical effects of Firebird stent and Yinyi stent implantation in patients with coronary heart disease and diabetes

Angiographic and Clinical Comparisons of Intravascular Ultrasound- Versus Angiography-Guided Drug-Eluting Stent Implantation for Patients with Chronic Total Occlusion Lesions: Two-Year Results from a Randomised AIR-CTO Study

Clinical Contrast Investigation of Firebird and Cypher Rapamycin Eluting Stent

Mid-term result of implantation of drug eluted stent for diabetic patients with multivessel coronary artery lesions

An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial

Safety and Efficacy of the Sirolimus-Eluting Stent in the Treatment of Patients with Lesions in Small Native Coronary Arteries